Literature DB >> 3917362

Micronutrient requirements of cancer patients.

F A Hoffman.   

Abstract

Several major factors may influence the micronutrient requirements of the patient with cancer. These factors include the metabolic state of the malignancy and its effects on host metabolism, the catabolic effects of antineoplastic therapy, and other physiologic stresses commonly associated with the treatment of cancer, i.e., surgery, fever and infection. Although the nutritional importance of vitamins, minerals and trace elements is recognized, the optimal daily dose that will preserve lean body mass without enhancing tumor growth, is not known. Recommended Dietary Allowances (RDAs), where established, are based on populations with nonmalignant diseases. However, supplementation with vitamins, minerals, and certain trace elements is recommended for the cancer patient who requires prolonged parenteral support, since clinically relevant deficiency states have been described. The effect of malignancy on the metabolism of several of these micronutrients (iron, ascorbic acid, alpha tocopherol, selenium, zinc, copper) is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917362     DOI: 10.1002/1097-0142(19850101)55:1+<295::aid-cncr2820551315>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Evidence-based roads to the promotion of health in old age.

Authors:  P Ljubuncic; A Globerson; A Z Reznick
Journal:  J Nutr Health Aging       Date:  2008-02       Impact factor: 4.075

2.  Trace elements in chronic sinusitis.

Authors:  M Onerci; S Kus
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

Review 3.  Scurvy in pediatric age group - A disease often forgotten?

Authors:  Anil Agarwal; Abbas Shaharyar; Anubrat Kumar; Mohd Shafi Bhat; Madhusudan Mishra
Journal:  J Clin Orthop Trauma       Date:  2015-01-05

Review 4.  Malignant disease: nutritional implications of disease and treatment.

Authors:  S Holmes; J W Dickerson
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 5.  Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.

Authors:  E Klimant; H Wright; D Rubin; D Seely; M Markman
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

6.  Vitamin C deficiency in an anticoagulated patient.

Authors:  George M Yousef; Lynne J Goebel
Journal:  J Gen Intern Med       Date:  2012-11-29       Impact factor: 5.128

Review 7.  A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project.

Authors:  Henning Cuhls; Milka Marinova; Stein Kaasa; Christiane Stieber; Rupert Conrad; Lukas Radbruch; Martin Mücke
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-07-20       Impact factor: 12.910

Review 8.  Why Vitamin C Could Be an Excellent Complementary Remedy to Conventional Therapies for Breast Cancer.

Authors:  Michela Codini
Journal:  Int J Mol Sci       Date:  2020-11-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.